128 related articles for article (PubMed ID: 34128388)
1. MiR-130a-3p Has Protective Effects in Alzheimer's Disease via Targeting DAPK1.
Wang Y; Shi M; Hong Z; Kang J; Pan H; Yan C
Am J Alzheimers Dis Other Demen; 2021; 36():15333175211020572. PubMed ID: 34128388
[TBL] [Abstract][Full Text] [Related]
2. H19/miR-130a-3p/DAPK1 axis regulates the pathophysiology of neonatal hypoxic-ischemia encephalopathy.
Feng M; Zhu X; Zhuo C
Neurosci Res; 2021 Feb; 163():52-62. PubMed ID: 32173462
[TBL] [Abstract][Full Text] [Related]
3. The Involvement of lncRNA HOTAIR/miR-130a-3p Axis in the Regulation of Voluntary Exercise on Cognition and Inflammation of Alzheimer's Disease.
Lu J; Liu L; Chen J; Zhi J; Li J; Li L; Jiang Z
Am J Alzheimers Dis Other Demen; 2022; 37():15333175221091424. PubMed ID: 35442818
[TBL] [Abstract][Full Text] [Related]
4. miR-143-3p Inhibits Aberrant Tau Phosphorylation and Amyloidogenic Processing of APP by Directly Targeting DAPK1 in Alzheimer's Disease.
Wang L; Shui X; Mei Y; Xia Y; Lan G; Hu L; Zhang M; Gan CL; Li R; Tian Y; Wang Q; Gu X; Chen D; Zhang T; Lee TH
Int J Mol Sci; 2022 Jul; 23(14):. PubMed ID: 35887339
[TBL] [Abstract][Full Text] [Related]
5. MiR-335-5p Inhibits β-Amyloid (Aβ) Accumulation to Attenuate Cognitive Deficits Through Targeting c-jun-N-terminal Kinase 3 in Alzheimer's Disease.
Wang D; Fei Z; Luo S; Wang H
Curr Neurovasc Res; 2020; 17(1):93-101. PubMed ID: 32003672
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-132-3p alleviates neuron apoptosis and impairments of learning and memory abilities in Alzheimer's disease by downregulation of HNRNPU stabilized BACE1.
Qu J; Xiong X; Hujie G; Ren J; Yan L; Ma L
Cell Cycle; 2021 Nov; 20(21):2309-2320. PubMed ID: 34585626
[TBL] [Abstract][Full Text] [Related]
7. Micro-RNA-137 Inhibits Tau Hyperphosphorylation in Alzheimer's Disease and Targets the CACNA1C Gene in Transgenic Mice and Human Neuroblastoma SH-SY5Y Cells.
Jiang Y; Xu B; Chen J; Sui Y; Ren L; Li J; Zhang H; Guo L; Sun X
Med Sci Monit; 2018 Aug; 24():5635-5644. PubMed ID: 30102687
[TBL] [Abstract][Full Text] [Related]
8. The emerging role of microRNA-4487/6845-3p in Alzheimer's disease pathologies is induced by Aβ25-35 triggered in SH-SY5Y cell.
Hu L; Zhang R; Yuan Q; Gao Y; Yang MQ; Zhang C; Huang J; Sun Y; Yang W; Yang JY; Min ZL; Cheng J; Deng Y; Hu X
BMC Syst Biol; 2018 Dec; 12(Suppl 7):119. PubMed ID: 30547775
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of miR-331-3p and miR-9-5p ameliorates Alzheimer's disease by enhancing autophagy.
Chen ML; Hong CG; Yue T; Li HM; Duan R; Hu WB; Cao J; Wang ZX; Chen CY; Hu XK; Wu B; Liu HM; Tan YJ; Liu JH; Luo ZW; Zhang Y; Rao SS; Luo MJ; Yin H; Wang YY; Xia K; Tang SY; Xie H; Liu ZZ
Theranostics; 2021; 11(5):2395-2409. PubMed ID: 33500732
[TBL] [Abstract][Full Text] [Related]
10. Long Non-Coding RNA BACE1-AS Modulates Isoflurane-Induced Neurotoxicity to Alzheimer's Disease Through Sponging miR-214-3p.
He W; Chi S; Jin X; Lu J; Zheng W; Yan J; Zhang D
Neurochem Res; 2020 Oct; 45(10):2324-2335. PubMed ID: 32681443
[TBL] [Abstract][Full Text] [Related]
11. Aberrant expression of miR-148a-3p in Alzheimer's disease and its protective role against amyloid-β induced neurotoxicity.
Zhang H; Liu W; Ge H; Li K
Neurosci Lett; 2021 Jun; 756():135953. PubMed ID: 33979697
[TBL] [Abstract][Full Text] [Related]
12. HAGLR promotes neuron differentiation through the miR-130a-3p-MeCP2 axis.
Wei B; Xiao GR; Wu CL; Xu YQ
Open Med (Wars); 2021; 16(1):1121-1131. PubMed ID: 34430707
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-22-3p ameliorates Alzheimer's disease by targeting SOX9 through the NF-κB signaling pathway in the hippocampus.
Xia P; Chen J; Liu Y; Cui X; Wang C; Zong S; Wang L; Lu Z
J Neuroinflammation; 2022 Jul; 19(1):180. PubMed ID: 35821145
[TBL] [Abstract][Full Text] [Related]
14. Upregulation of miR-34a by Inhibition of IRE1
Li Q; Liu T; Yang S; Zhang Z
Oxid Med Cell Longev; 2019; 2019():2140427. PubMed ID: 31281568
[TBL] [Abstract][Full Text] [Related]
15. MiR-485-3p serves as a biomarker and therapeutic target of Alzheimer's disease via regulating neuronal cell viability and neuroinflammation by targeting AKT3.
Yu L; Li H; Liu W; Zhang L; Tian Q; Li H; Li M
Mol Genet Genomic Med; 2021 Jan; 9(1):e1548. PubMed ID: 33220166
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of miR-132-3p contributes to neuronal protection in in vitro and in vivo models of Alzheimer's disease.
Zeng C; Meng X; Mai D; Xu K; Qu S
Behav Brain Res; 2022 Jan; 417():113584. PubMed ID: 34536429
[TBL] [Abstract][Full Text] [Related]
17. miR-204-3p/Nox4 Mediates Memory Deficits in a Mouse Model of Alzheimer's Disease.
Tao W; Yu L; Shu S; Liu Y; Zhuang Z; Xu S; Bao X; Gu Y; Cai F; Song W; Xu Y; Zhu X
Mol Ther; 2021 Jan; 29(1):396-408. PubMed ID: 32950103
[TBL] [Abstract][Full Text] [Related]
18. Extracellular vesicles derived from astrocyte-treated with haFGF
Peng D; Wang Y; Xiao Y; Peng M; Mai W; Hu B; Jia Y; Chen H; Yang Y; Xiang Q; Su Z; Zhang Q; Huang Y
Theranostics; 2022; 12(8):3862-3881. PubMed ID: 35664060
[No Abstract] [Full Text] [Related]
19. MiR-130a-3p attenuates activation and induces apoptosis of hepatic stellate cells in nonalcoholic fibrosing steatohepatitis by directly targeting TGFBR1 and TGFBR2.
Wang Y; Du J; Niu X; Fu N; Wang R; Zhang Y; Zhao S; Sun D; Nan Y
Cell Death Dis; 2017 May; 8(5):e2792. PubMed ID: 28518142
[TBL] [Abstract][Full Text] [Related]
20. Differential Expression of miR-381-3p in Alzheimer's Disease Patients and Its Role in Beta-Amyloid-Induced Neurotoxicity and Inflammation.
Zhang M; Liu Y; Teng P; Yang Q
Neuroimmunomodulation; 2022; 29(3):211-219. PubMed ID: 34749366
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
